Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer

SIMPLE SUMMARY: Pre-clinical models are required to develop new therapeutics to improve patient care. In the prostate cancer field, significant progress has been made in the development of in vivo models but with a predominant focus on transgenics, which are time and cost prohibitive. Conversely, ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Haughey, Charles M., Mukherjee, Debayan, Steele, Rebecca E., Popple, Amy, Dura-Perez, Lara, Pickard, Adam, Patel, Mehjabin, Jain, Suneil, Mullan, Paul B., Williams, Rich, Oliveira, Pedro, Buckley, Niamh E., Honeychurch, Jamie, S. McDade, Simon, Illidge, Timothy, Mills, Ian G., Eddie, Sharon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599844/
https://www.ncbi.nlm.nih.gov/pubmed/33003551
http://dx.doi.org/10.3390/cancers12102804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599844/
https://www.ncbi.nlm.nih.gov/pubmed/33003551
http://dx.doi.org/10.3390/cancers12102804

Ejemplares similares